EL vs FGEN · rev $15.05B vs rev $29.6M
Estee Lauder Companies Inc (EL) versus FibroGen Inc (FGEN) — a side-by-side from cached financials, not a winner call.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
EL currently screens at market cap $31.92B. FGEN currently screens at market cap $39.3M.
Not investment advice. Open the EL and FGEN stock pages for the full models.
Not investment advice.